BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Lina Elsalem, Ahmad A Jum'ah, Mahmoud A Alfaqih, Osama Aloudat. <p>The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives</p>Clinical and Experimental Gastroenterology 2020; : 151 doi: 10.2147/CEG.S243337
2
Monika Laszkowska, Aaron Oh, Chin Hur. Screening for Upper Gastrointestinal Malignancies in the United States—Which Immigrant Groups Should Be Considered High-Risk?Gastroenterology 2020; 158(1): 4 doi: 10.1053/j.gastro.2019.09.047
3
Liting Xi, Jinzhou Zhu, Huixian Zhang, Merlin Muktiali, Chunfang Xu, Airong Wu. Epidemiological Trends in Gastrointestinal Cancers in China: An Ecological StudyDigestive Diseases and Sciences 2019; 64(2): 532 doi: 10.1007/s10620-018-5335-6
4
Li-Ping Liu, Xi-Ping Sheng, Tian-Kui Shuai, Yong-Xun Zhao, Bin Li, Yu-Min Li. <i>Helicobacter pylori</i> promotes invasion and metastasis of gastric cancer by enhancing heparanase expressionWorld Journal of Gastroenterology 2018; 24(40): 4565-4577 doi: 10.3748/wjg.v24.i40.4565
5
Jiro Watari, Chiyomi Ito, Tadakazu Shimoda, Toshihiko Tomita, Tadayuki Oshima, Hirokazu Fukui, Kiron M. Das, Hiroto Miwa. DNA methylation silencing of microRNA gene methylator in the precancerous background mucosa with and without gastric cancer: Analysis of the effects of H. pylori eradication and long-term aspirin useScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49069-1
6
You Wu, Tun Su, Xianzhu Zhou, Nonghua Lu, Zhaoshen Li, Yiqi Du. Awareness and attitudes regarding Helicobacter pylori infection in Chinese physicians and public population: A national cross‐sectional survey Helicobacter 2020;  doi: 10.1111/hel.12705
7
Ka-Shing Cheung, Wai K Leung, Wai-Kay Seto. Application of Big Data analysis in gastrointestinal researchWorld Journal of Gastroenterology 2019; 25(24): 2990-3008 doi: 10.3748/wjg.v25.i24.2990
8
Alexios-Fotios A. Mentis, Efthimios Dardiotis. Helicobacter pylori Eradication for Metachronous Gastric Cancer: An Unsuitable Methodology Impeding Broader Clinical UsageFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00090
9
Ka Shing Cheung, Wai K. Leung. Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after Helicobacter pylori eradicationOncotarget 2018; 9(97): 36891 doi: 10.18632/oncotarget.26382
10
I. N. Voynovan, Yu. V. Embutnieks, D. V. Mareeva, S. V. Kolbasnikov, D. S. Bordin. Helicobacter pylori as a risk factor for gastric cancer: the evidence and primary prevention strategyAlmanac of Clinical Medicine 2019; 47(6): 535 doi: 10.18786/2072-0505-2019-47-052
11
Ka Shing Cheung, Esther W. Chan, Lijia Chen, Wai Kay Seto, Ian C.K. Wong, Wai K. Leung. Diabetes Increases Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study With Propensity Score AnalysisDiabetes Care 2019; 42(9): 1769 doi: 10.2337/dc19-0437
12
Ka Shing Cheung, Esther W Chan, Angel Y S Wong, Lijia Chen, Wai Kay Seto, Ian C K Wong, Wai K Leung. Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori EradicationJNCI: Journal of the National Cancer Institute 2019; 111(5): 484 doi: 10.1093/jnci/djy144
13
Ka Shing Cheung, Wai K. Leung. Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidenceTherapeutic Advances in Gastroenterology 2019; 12: 175628481983451 doi: 10.1177/1756284819834511